During Matthew
Insider CIK 1704631 · OVID President and CSO, Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| OVID Ovid Therapeutics Inc. | A Award deriv | 2019-04-01 | 2019-04-03 | 75,000 | — | $0 | 75,000 | SEC↗ |
| OVID Ovid Therapeutics Inc. | A Award deriv | 2019-02-24 | 2019-02-26 | 70,000 | — | $0 | 70,000 | SEC↗ |
| OVID Ovid Therapeutics Inc. | A Award deriv | 2018-01-19 | 2018-01-23 | 110,000 | — | $0 | 110,000 | SEC↗ |
| OVID Ovid Therapeutics Inc. | C Conversion deriv | 2017-05-10 | 2017-05-10 | 28,245 | — | $0 | 0 | SEC↗ |
| OVID Ovid Therapeutics Inc. | C Conversion | 2017-05-10 | 2017-05-10 | 28,245 | — | $0 | 4,307,314 | SEC↗ |